HPC Biosciences has informed the BSE that its board of directors will meet on January 14 to consider a proposal to split/sub-divide the face value of the equity shares of the company. The current face value of the stock of HPC Bioscience, listed on BSE’s SME window, is ₹10. The board will also consider altering the Capital Clause of the Memorandum of Association of the company, consequent upon split of equity shares. Apart from these, the board will fix the day, date, time and venue of the extraordinary general meeting of the company for the proposed stock split. Shares of HPC Biosciences slipped 1.25 per cent at ₹474.
ECE Industries has clarified that its board of directors will meet on January 19 to consider a proposal to delist the shares of the company from any one of the recognised stock exchanges - either NSE or BSE. That means, shareholders of the company will not be given any exit opportunity, as the shares will continue to remain listed on a major exchange. The company's clarification follows the steep rise in the share prices following its delisting notification on January 9. Post-announcement, the stock of ECE Industries fell to ₹146.25, from the day's high of ₹167.75. The stock on Friday closed at ₹152.50.